Marex Group (MRX) 6-K: Directors and Officers purchase shares

When was the Marex insider share purchase announcement made?

Is this filing related to issuing new MRX shares?

Rhea-AI Filing Summary

FAQ

Q: Where can I find details on the directors’ and officers’ share purchases for MRX?

Q: What is the form type filed by Marex Group (MRX)?

What did Marex Group (MRX) disclose in this Form 6-K?

Does the 6-K include financial results or guidance for MRX?

What is the form type filed by Marex Group (MRX)?

The company issued the press release on October 15, 2025.

The filing references purchases by directors and officers and furnishes a press release; it does not state an issuance of new shares in the provided excerpt.

Details are in Exhibit 99.1, titled “Marex announces share purchases by Directors and Officers.”

Marex filed a Form 6-K, a report of a foreign private issuer.

Marex Group plc furnished a Form 6-K noting a company press release on insider share activity.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Marex Group plc furnished a Form 6-K noting a company press release on insider share activity. On October 15, 2025, the company announced that its directors and officers purchased ordinary shares.

The press release is provided as Exhibit 99.1 titled “Marex announces share purchases by Directors and Officers.”

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Marex reported a press release announcing ordinary share purchases by its directors and officers, furnished as Exhibit 99.1.

This report furnishes a press release about insider share purchases; it does not present financial results in the provided excerpt.

Marex Group plc

Date: October 15, 2025

/s/ Robert Irvin

Robert Irvin

Chief Financial Officer

Marex filed a Form 6-K, a report of a foreign private issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 10/15/2025 - 12:00 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number: 001-42020

MAREX GROUP PLC

(Translation of registrant’s name into English)

155 Bishopsgate

London EC2M 3TQ

United Kingdom

+44 20 7655 6000

140 East 45th Street, 10th Floor

New York, New York 10017

(212) 618-2800

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

Purchase of Ordinary Shares by Directors and Officers

On October 15, 2025, Marex Group plc (the “Company”) issued a press release titled “Marex announces share purchases by Directors and Officers”. A copy of the press release is furnished as Exhibit 99.1 herewith.

EXHIBIT INDEX

The following exhibit is furnished as part of this Form 6-K:


Exhibit No.		Description

99.1		Press release dated October 15, 2025 titled “Marex announces share purchases by Directors and Officers”

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Source: View Original Filing on SEC EDGAR

Keep reading